Recruiting

Genetics

Sponsor:

The Cleveland Clinic

Code:

NCT02357238

Conditions

Uveitis

Infectious Uveitis

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Accepted

Study Details

Brief summary:

In order to improve the investigators knowledge about uveitis and the underlying mechanism of disease, the investigators propose collecting blood from patients with uveitis, isolating DNA and sequencing the DNA to identify genetic mutations or associations in these patients.

Conditions

Uveitis

Infectious Uveitis

Study ID

NCT02357238

Start date

Jan, 2011

Status verified date

Mar, 2026

Completion date

Jan, 2030

Anticipated

Primary completion date

Jan, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Any patient above with the diagnosis of uveitis.
  • Any patient with a diagnosis of infectious uveitis such as toxoplasmosis retinochoroiditis, herpes associated retinitis.

Exclusion Criteria:

  • Patients who are unable to give consent
  • Patients in whom an adequated blood sample can not be obtained.

Study Design

Enrollment

1500 participants

Anticipated

Interventions and Outcome Measures

Arms

Uveitis

Uveitis or infectious uveitis patients

Primary outcome measure

  • Non infectious uveitis [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Kimberly M Baynes, BSN, RN, COA

216-444-2566baynesk@ccf.org

Locations

Cleveland Clinic Foundation

Recruiting

Cleveland, Ohio, United States, 44195

Contacts

Kimberly M Baynes, COA

216-444-2566baynesk@ccf.org

Principal Investigator:

Sunil K. Srivastava, M.D.

More Information

Sponsor

The Cleveland Clinic

Last update posted

Mar 4, 2026

Last verified

Mar, 2026

Keywords

  • Uveitis
  • Infectious

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Cleveland Clinic on 2026-03-04.